Valuation: APTOCROM Inc.

Market Cap 26.04B 19.41M 17.68M 16.29M 14.82M 27.79M 1.8B 29.21M 198M 78.79M 982M 72.81M 71.28M 3.08B P/E 2024
-2.12x
P/E 2025 -9.5x
Enterprise Value 8.84B 6.59M 6M 5.53M 5.03M 9.44M 610M 9.92M 67.33M 26.76M 333M 24.73M 24.21M 1.05B EV / Sales 2024
4.85x
EV / Sales 2025 3.87x
Free-Float
14.22%
Yield 2024 *
-
Yield 2025 -
1 day-0.81%
1 week+3.93%
Current month-2.16%
1 month-7.12%
3 months-10.36%
6 months-43.76%
Current year-65.58%
1 week 1,555
Extreme 1555
2,120
1 month 1,382
Extreme 1382
2,120
Current year 1,382
Extreme 1382
5,400
1 year 1,382
Extreme 1382
5,940
3 years 1,382
Extreme 1382
18,800
5 years 1,382
Extreme 1382
75,400
10 years 1,382
Extreme 1382
333,000
Manager TitleAgeSince
Chief Executive Officer 70 2022-03-22
Comptroller/Controller/Auditor 51 -
Sales & Marketing 62 -
Director TitleAgeSince
Director/Board Member 59 -
Director/Board Member 70 2022-03-22
Director/Board Member 63 2017-01-09
Change 5-day change 1-year change 3-year change Capi.($)
-0.81%+3.93%-68.71%-90.25% 19.41M
-0.30%-6.68%+29.12%+125.42% 1,200B
+1.25%-5.35%+33.19%+80.42% 651B
+0.94%-2.99%+24.73%+106.93% 506B
-0.60%-1.95%+27.26%+67.32% 377B
+0.69%-9.50%+40.80%+30.23% 330B
+0.41%-4.70%+27.23%+51.59% 288B
+0.81%-4.08%-1.74%+32.71% 272B
-0.15%-6.45%+29.63%+64.18% 236B
-0.06%-0.98%+33.15%+118.99% 206B
Average +0.25%-3.80%+17.47%+58.75% 407B
Weighted average by Cap. +0.40%-5.19%+28.03%+87.49%

Financials

2024 2025
Net sales 16.4B 12.22M 11.13M 10.26M 9.33M 17.51M 1.13B 18.4M 125M 49.63M 618M 45.87M 44.9M 1.94B 9.81B 7.31M 6.66M 6.14M 5.58M 10.47M 677M 11M 74.67M 29.68M 370M 27.43M 26.85M 1.16B
Net income -28.09B -20.94M -19.07M -17.57M -15.99M -29.99M -1.94B -31.52M -214M -85.02M -1.06B -78.57M -76.91M -3.32B -5.56B -4.14M -3.77M -3.48M -3.16M -5.94M -384M -6.24M -42.33M -16.82M -210M -15.55M -15.22M -658M
Net Debt -25.07B -18.69M -17.02M -15.68M -14.26M -26.76M -1.73B -28.12M -191M -75.86M -945M -70.11M -68.63M -2.97B -17.19B -12.82M -11.67M -10.76M -9.78M -18.35M -1.19B -19.29M -131M -52.03M -648M -48.08M -47.07M -2.03B
Projected Income Statement - Annual - APTOCROM Inc.
Logo APTOCROM Inc.
Aptocrom Inc, formerly AP Healthcare Inc, is a Korea-based company primarily engaged in the pharmaceutical business. The Company operates its business through three segments. The Pharmaceutical Business segment is mainly engaged in the distribution and sale of drugs such as digestive organs medicine, outer skin medicine, nutrient tonic alteration and antibiotics. The Insulation Business segment is mainly engaged in the production, design, manufacturing and construction of industrial insulation. The Rental Business segment is mainly engaged in the real estate business such as offices and laboratories. The Company sells its products in domestic and overseas markets.
Employees
11
Date Price Change Volume
26-11-20 ₩1,721.00 -0.81% 1,021
26-11-19 ₩1,735.00 +0.58% 4,714
26-11-18 ₩1,725.00 +0.17% 3,451
26-11-17 ₩1,722.00 +4.81% 13,837
26-11-16 ₩1,643.00 -0.79% 4,033
  1. Stock Market
  2. Stocks
  3. A109960 Stock